MedPath

Therapeutic Plasma Exchange in Thyrotoxicosis

Completed
Conditions
Thyrotoxicosis
Registration Number
NCT04485975
Lead Sponsor
Baskent University
Brief Summary

Therapeutic plasma exchange (TPE) is indicated in cases where antithyroid medications cannot be used due to the side effects or attain no adequate hormonal suppression response at the highest dosage and in cases of rapid onset of clinical symptoms. This study presents the treatment results of patients who underwent TPE and subsequently operated for thyrotoxicosis.

Detailed Description

Background: Therapeutic plasma exchange (TPE) is indicated in cases where antithyroid medications cannot be used due to the side effects or attain no adequate hormonal suppression response at the highest dosage and in cases of rapid onset of clinical symptoms. This study presents the treatment results of patients who underwent TPE and subsequently operated for thyrotoxicosis.

Methods: The files of 27 patients who underwent preoperative TPE for thyrotoxicosis between January 1999 and February 2019 were retrospectively analyzed. The demographic and clinical features of the patients were included.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria
  • thyrotoxicosis unresponsive to medication
  • adverse reaction to the medications
  • need for rapid treatment in patients that need urgent surgery
Read More
Exclusion Criteria
  • The patients who did not undergo surgery post-therapeutic plasma exchange
  • Preoperative hypocalcemia,
  • hemodynamically unstable patients
  • patients not suitable for central catheter placement
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Thyroid hormone levels of patients after therapeutic plasma exchange1 week before the operation

Concentration of serum thyroid hormone levels before thyroidectomy

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath